JP2005112847A - Synthetic resin porous particle combined with hydroxyapatite particle, external preparation, and cosmetic - Google Patents
Synthetic resin porous particle combined with hydroxyapatite particle, external preparation, and cosmetic Download PDFInfo
- Publication number
- JP2005112847A JP2005112847A JP2004216076A JP2004216076A JP2005112847A JP 2005112847 A JP2005112847 A JP 2005112847A JP 2004216076 A JP2004216076 A JP 2004216076A JP 2004216076 A JP2004216076 A JP 2004216076A JP 2005112847 A JP2005112847 A JP 2005112847A
- Authority
- JP
- Japan
- Prior art keywords
- particles
- hydroxyapatite
- porous
- particle
- resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 title claims abstract description 248
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 95
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 95
- 239000002537 cosmetic Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 229920003002 synthetic resin Polymers 0.000 title claims description 23
- 239000000057 synthetic resin Substances 0.000 title claims description 21
- -1 external preparation Substances 0.000 title description 27
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 9
- 229920005989 resin Polymers 0.000 claims description 45
- 239000011347 resin Substances 0.000 claims description 45
- 238000004519 manufacturing process Methods 0.000 claims description 38
- 239000000178 monomer Substances 0.000 claims description 31
- 210000002374 sebum Anatomy 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 25
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 16
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 16
- 229920000620 organic polymer Polymers 0.000 claims description 14
- 239000003925 fat Substances 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 239000003463 adsorbent Substances 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 24
- 238000007796 conventional method Methods 0.000 abstract description 7
- 239000000725 suspension Substances 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 239000000284 extract Substances 0.000 description 27
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 24
- 238000010521 absorption reaction Methods 0.000 description 16
- 239000000843 powder Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 239000006185 dispersion Substances 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000011148 porous material Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 9
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 9
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 9
- 239000005642 Oleic acid Substances 0.000 description 9
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 9
- 235000013339 cereals Nutrition 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 9
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 9
- 235000021313 oleic acid Nutrition 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000010419 fine particle Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000010557 suspension polymerization reaction Methods 0.000 description 7
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 238000000635 electron micrograph Methods 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007870 radical polymerization initiator Substances 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229940008396 carrot extract Drugs 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000000879 optical micrograph Methods 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000012798 spherical particle Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- JMYZLRSSLFFUQN-UHFFFAOYSA-N (2-chlorobenzoyl) 2-chlorobenzenecarboperoxoate Chemical compound ClC1=CC=CC=C1C(=O)OOC(=O)C1=CC=CC=C1Cl JMYZLRSSLFFUQN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- FCYVWWWTHPPJII-UHFFFAOYSA-N 2-methylidenepropanedinitrile Chemical compound N#CC(=C)C#N FCYVWWWTHPPJII-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000012674 dispersion polymerization Methods 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940048820 edetates Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- ULLDRQCJTSHDDT-UHFFFAOYSA-N penta-2,3,4-trienenitrile Chemical compound C=C=C=CC#N ULLDRQCJTSHDDT-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002459 porosimetry Methods 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
Description
本発明は新規な構造を有する多孔性粒子及びその製造方法に関する。さらに本発明は、この多孔性粒子を含有する皮脂の不飽和脂肪酸を選択的に吸着する外用剤又は化粧料に関する。 The present invention relates to a porous particle having a novel structure and a method for producing the same. Furthermore, this invention relates to the external preparation or cosmetics which selectively adsorb | suck the unsaturated fatty acid of sebum containing this porous particle.
ハイドロキシアパタイト(又はヒドロキシアパタイト或いはHAPともいう)は、Ca10(PO4)6(OH)2で表される物質で歯骨など人体に存在する無機質である。皮脂や皮脂中の不飽和脂肪酸を吸着させる外用剤、あるいは化粧膜の化粧もち向上のために顔料として配合した化粧料が知られている(例えば特許文献1,2,3参照)。
しかしながらハイドロキシアパタイトをそのまま化粧料や外用剤に配合した場合、ざらつきなど使用感の悪化を招き、また凝集によって効果的に皮脂の吸着ができないなどの問題が指摘されていた。このためハイドロキシアパタイトを球状に加工する技術(例えば特許文献4,5,6参照)、顔料表面にハイドロキシアパタイトを沈着させる技術(例えば特許文献7参照)が開発されている。しかしこれらの技術はいずれも、物理的な処理(例えば、静電気処理や混合圧縮処理)によって樹脂や顔料基材の表面にハイドロキシアパタイトを析出させたり、あるいはバインディング剤によって接着させたりするため、所望するだけの量のハイドロキシアパタイトを被覆させることができなかった。又、ハイドロキシアパタイトの結合状態が不安定であったり、あるいは粒子の表面にハイドロキシアパタイトが不均一に結合する等の欠点があった。このため、皮脂や皮脂中の不飽和脂肪酸を吸着する外用剤、あるいは化粧膜の化粧もち向上のために顔料としてハイドロキシアパタイトを配合した化粧料であっても効果的に皮脂の吸着をすることができなかった。
Hydroxyapatite (or hydroxyapatite or HAP) is a substance represented by Ca 10 (PO 4 ) 6 (OH) 2 and is an inorganic substance present in the human body such as a tooth bone. Known are external preparations that adsorb sebum and unsaturated fatty acids in sebum, or cosmetics formulated as pigments for improving the makeup of cosmetic films (see, for example, Patent Documents 1, 2, and 3).
However, when hydroxyapatite is directly blended into cosmetics and external preparations, problems have been pointed out, such as roughening and a feeling of use being deteriorated, and sebum cannot be effectively adsorbed by aggregation. For this reason, techniques for processing hydroxyapatite into a spherical shape (see, for example, Patent Documents 4, 5, and 6) and techniques for depositing hydroxyapatite on the pigment surface (for example, see Patent Document 7) have been developed. However, both of these techniques are desirable because hydroxyapatite is deposited on the surface of the resin or pigment base material by physical treatment (for example, electrostatic treatment or mixed compression treatment), or bonded with a binding agent. Only a sufficient amount of hydroxyapatite could not be coated. In addition, there are drawbacks such as the bonding state of hydroxyapatite being unstable or the bonding of hydroxyapatite non-uniformly to the surface of the particles. For this reason, even sebum, an external preparation that adsorbs unsaturated fatty acids in sebum, or a cosmetic containing hydroxyapatite as a pigment to improve the makeup of the cosmetic film can effectively adsorb sebum. could not.
又、従来の技術においては、アクリルアミドやポリビニルアルコールポリマーからなる有機高分子合成多孔性粒子は吸油、吸水速度に優れることから化粧もちの向上のために化粧料に配合されていた(例えば特許文献8参照)。しかしながら、単に多孔性にしただけでは水分の吸着と一部の皮脂を吸収するだけであって、好ましくない。好ましい皮膚外用剤としては、皮膚にとって刺激になりうる不飽和脂肪酸を効果的に吸着する剤である。
特に、脂肪酸、なかでも不飽和脂肪酸は、酸化されることにより皮膚を刺激するが、皮脂のみを吸着してもこの不飽和脂肪酸を吸着しないと皮膚刺激低減の効果は低い。又、吸油量も十分でないため化粧もちについても効果は低かった。このため従来の合成多孔性粒子のもつ皮脂の脂肪酸吸着性を改良することが望まれていた。
In the prior art, organic polymer synthetic porous particles made of acrylamide or polyvinyl alcohol polymer are excellent in oil absorption and water absorption speed, and are therefore blended in cosmetics to improve makeup (for example, Patent Document 8). reference). However, simply making it porous is not preferable because it only adsorbs moisture and absorbs some sebum. A preferred external preparation for skin is an agent that effectively adsorbs unsaturated fatty acids that can be irritating to the skin.
In particular, fatty acids, especially unsaturated fatty acids, irritate the skin by being oxidized, but the effect of reducing skin irritation is low if these unsaturated fatty acids are not adsorbed even if only sebum is adsorbed. In addition, since the amount of oil absorption was not sufficient, the effect was also low for makeup. For this reason, it has been desired to improve the fatty acid adsorptivity of sebum of conventional synthetic porous particles.
本発明者らは、肌を正常に保ち、さらには肌荒れ防止、肌荒れ改善に対して有効な方法がないか鋭意研究した結果、皮脂成分のうち肌に悪影響を及ぼす皮脂老廃物を除去するために、ハイドロキシアパタイトを多孔性粒子の表面に結合させたものは皮脂老廃物である遊離脂肪酸及び過酸化脂質に対して特に選択的な吸着性を示し、肌荒れ防止、肌荒れ改善さらにはニキビ患者の炎症を抑制する効果のあることを見出した。しかしながらハイドロキシアパタイト粉末をそのまま皮膚外用剤中に配合したならば、ハイドロキシアパタイト粉末は凝集性が強いため肌への広がりが不十分で、皮脂老廃物に対する吸着効果が十分に発揮されない欠点があった。このため本発明者らは樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合している新規な多孔性粒子を開発し本発明を完成させた。したがって、本発明は上記のとおり新規な、多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合していることを特徴とする多孔性粒子を提供することを課題とする。さらにまた、本発明は、前記粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合していることを特徴とする多孔性粒子を配合した、外用剤及び化粧料、特にメイクアップ化粧料、スキンケア化粧料を提供することを課題とする。 In order to remove sebum waste that has an adverse effect on the skin among the sebum components, the present inventors have intensively studied whether there is an effective method for keeping the skin normal, further preventing rough skin, and improving rough skin. , Hydroxyapatite bonded to the surface of porous particles has a particularly selective adsorptivity to free fatty acids and lipid peroxides, which are sebum waste products, to prevent rough skin, improve rough skin, and even cause inflammation in acne patients. It has been found that there is an inhibitory effect. However, if the hydroxyapatite powder is directly blended into the external preparation for skin, the hydroxyapatite powder has a strong cohesiveness, so that it does not sufficiently spread to the skin and the effect of adsorbing sebum waste products is not fully exhibited. For this reason, the present inventors have developed novel porous particles in which hydroxyapatite particles having an average particle size of 0.1 to 1 μm are firmly bonded to the surface of the resin, thereby completing the present invention. Accordingly, the present invention provides a porous particle characterized in that a hydroxyapatite particle having an average particle diameter of 0.1 to 1 μm is firmly bonded to the surface of a resin constituting the porous fine particle as described above. The issue is to provide. Furthermore, the present invention provides an external preparation containing porous particles characterized in that hydroxyapatite particles having an average particle size of 0.1 to 1 μm are firmly bonded to the surface of the resin constituting the particles. And cosmetics, particularly makeup cosmetics and skin care cosmetics.
本発明者らは、本発明者らが見出した新規な、多孔性粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が結合している多孔性粒子は、従来のハイドロキシアパタイトや多孔質粒子と比較して、皮脂をより多く吸収し、且つ効果的に皮脂中の不飽和脂肪酸を吸着することで使用感の悪化や剤型への影響を与えずに皮膚刺激の低減や、化粧もちの向上が実現することを見出した。この粒子は従来のハイドロキシアパタイトで被覆された樹脂からなる粒子と異なっており、多孔質粒子の表面にハイドロキシアパタイトが強固に結合しているものである。この多孔性粒子は従来のような、圧着や接着、静電気的結合ではなく、目的とする高分子樹脂の原料となるモノマーを重合させ、多孔性粒子を合成する際に、モノマー中にハイドロキシアパタイトを共存させるという、まったく新規な方法を採用することによって得られるものである。従来技術には開示も示唆もなかった新規技術である。 The present inventors have discovered a novel porous particle in which a part of a hydroxyapatite particle having an average particle size of 0.1 to 1 μm is bonded to the surface of a resin constituting the porous particle, which has been found by the present inventors. Compared to conventional hydroxyapatite and porous particles, it absorbs more sebum and effectively adsorbs unsaturated fatty acids in sebum without affecting the feeling of use or affecting the dosage form. It has been found that reduction of skin irritation and improvement of makeup are realized. These particles are different from conventional particles made of a resin coated with hydroxyapatite, and the hydroxyapatite is firmly bonded to the surface of the porous particles. These porous particles are not pressure-bonded, bonded, or electrostatically bonded as in the past, but the monomer used as the raw material for the target polymer resin is polymerized to synthesize hydroxyapatite in the monomer. It is obtained by adopting a completely new method of coexistence. It is a new technology that has not been disclosed or suggested in the prior art.
すなわち、本発明は下記1乃至9に示すとおりの発明である。
1.空隙率5〜50%、粒子の平均粒径が1〜20μmの有機高分子合成樹脂からなる多孔性粒子で該多孔性合成樹脂粒子の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子が結合していることを特徴とする多孔性粒子。
2.ハイドロキシアパタイトが多孔性樹脂の重量に対して10〜50重量%結合している1記載の多孔性粒子。
3.多孔性粒子の形状がほぼ球状である1又は2記載の多孔性粒子。
4.多孔性粒子の合成にあたり、原料となる合成樹脂モノマーの溶液中にハイドロキシアパタイト粒子を分散させた後重合反応工程、多孔質化工程、粒子形成工程を行うことを特徴とする1乃至3のいずれかに記載の多孔性粒子の製造方法。
5.1乃至3記載の粒子を含有することを特徴とする皮膚外用剤。
6.皮膚外用剤が、皮脂の不飽和脂肪酸を選択的に吸着するものである5記載の外用剤。
7.1乃至3のいずれかに記載の多孔性粒子を含有する化粧料。
8.1乃至3のいずれかに記載の多孔性粒子を含有する皮脂、油脂、脂肪、脂質系成分の吸着剤。
9.1乃至3のいずれかに記載の多孔性粒子を含有する脂質系成分担持剤。
That is, the present invention is as shown in the following 1 to 9.
1. Hydroxyapatite particles having an average particle diameter of 0.1 to 1 μm on the surface of the porous synthetic resin particles are porous particles made of an organic polymer synthetic resin having a porosity of 5 to 50% and an average particle diameter of 1 to 20 μm. Porous particles characterized by being bonded.
2. 2. The porous particle according to 1, wherein hydroxyapatite is bonded to 10 to 50% by weight based on the weight of the porous resin.
3. 3. The porous particle according to 1 or 2, wherein the porous particle has a substantially spherical shape.
4). Any one of 1 to 3 characterized in that in the synthesis of the porous particles, hydroxyapatite particles are dispersed in a solution of a synthetic resin monomer as a raw material, followed by a polymerization reaction step, a porosification step, and a particle formation step. The manufacturing method of the porous particle as described in above.
A skin external preparation characterized by containing the particles according to 5.1 to 3.
6). The external preparation according to 5, wherein the external preparation for skin selectively absorbs unsaturated fatty acids in sebum.
7.1 A cosmetic containing the porous particles according to any one of 1 to 3.
8.1 An adsorbent for sebum, oil, fat, and lipid components containing the porous particles according to any one of 1 to 3.
A lipid-based component carrier containing the porous particles according to any one of 9.1 to 3.
本発明の実施により、新規な、多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合していることを特徴とする多孔性粒子及びその製造方法が提供される。
さらにまた、本発明の実施により、前記粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合していることを特徴とする多孔性粒子を配合した、外用剤及び化粧料、特にメイクアップ化粧料、スキンケア化粧料が提供される。
本発明の粒子を配合した外用剤、又は化粧料は従来の外用剤や化粧料に比べて優れた使用感と炎症抑制作用を有する。本発明の化粧料は化粧もち及び密着性に優れ、高い吸油性と皮脂脂肪酸の選択的吸着作用を有する。油脂類を担持する材料として、食品や一般工業材料に添加使用することが可能である。
By carrying out the present invention, it is characterized in that a novel hydroxyapatite particle body having an average particle size of 0.1 to 1 μm is bonded to the surface of a new resin constituting porous fine particles. Porous particles and methods for making the same are provided.
Furthermore, by carrying out the present invention, the porous material is characterized in that a part of hydroxyapatite particles having an average particle size of 0.1 to 1 μm are bonded to the surface of the resin constituting the particles in a state of being embedded. External preparations and cosmetics, in particular makeup cosmetics and skin care cosmetics, containing the functional particles are provided.
The external preparation or cosmetic containing the particles of the present invention has an excellent feeling of use and inflammation suppression compared to conventional external preparations and cosmetics. The cosmetic of the present invention is excellent in makeup and adhesion, has high oil absorption and sebum fatty acid selective adsorption. As a material for supporting oils and fats, it can be added to foods and general industrial materials.
本発明に使用するハイドロキシアパタイトは、Ca10(PO4)6(OH)2で表される物質で、歯骨など人体に存在する無機質である。ハイドロキシアパタイト粉末は、通常例えば以下のような湿式法あるいは乾式法によって調製される。
すなわち、湿式法の例としては、水酸化カルシウムとリン酸を水溶液中で反応させて得る方法、乾式法の例としては、炭酸カルシウムとリン酸カルシウムを空気中あるいは水蒸気雰囲気中かつ高温下で反応させて得る方法などがある。本発明に使用するハイドロキシアパタイトの粒子径は0.1μm〜1μmであって、形状は球状又は、不定形粒子であることが望ましい。このため湿式法での調製が好ましいが所望する条件を満たすものであればいずれの合成法であっても支障がない。ハイドロキシアパタイトの粒子径が0.1μmに満たない場合は、多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合している多孔性粒子の合成時に凝集が起こりやすく、また目的とする脂肪酸の吸収に効果的ではない。一方ハイドロキシアパタイトの粒子径が1μmを超えると、多孔性微粒子を構成する樹脂の表面に結合困難となる。また、ハイドロキシアパタイトの形状を球状又は不定形粒状とすることで、皮膚に対するざらつきの少ない使用感の優れた、より多くの不飽和脂肪酸を選択的に吸着する多孔性粒子とすることができる。
Hydroxyapatite used in the present invention is a substance represented by Ca 10 (PO 4 ) 6 (OH) 2 and is an inorganic substance present in the human body such as a tooth bone. The hydroxyapatite powder is usually prepared by, for example, the following wet method or dry method.
That is, as an example of a wet method, a method obtained by reacting calcium hydroxide and phosphoric acid in an aqueous solution, and as an example of a dry method, calcium carbonate and calcium phosphate are reacted in air or in a steam atmosphere at a high temperature. There are ways to get it. Hydroxyapatite used in the present invention preferably has a particle diameter of 0.1 μm to 1 μm and a spherical or irregular shape. For this reason, preparation by a wet method is preferable, but any synthesis method can be used as long as it satisfies the desired conditions. When the particle diameter of hydroxyapatite is less than 0.1 μm, the hydroxyapatite particles having an average particle diameter of 0.1 to 1 μm are partially embedded in the surface of the resin constituting the porous fine particles. Aggregation is likely to occur during the synthesis of the porous particles, and is not effective in absorbing the target fatty acid. On the other hand, when the particle diameter of hydroxyapatite exceeds 1 μm, it becomes difficult to bond to the surface of the resin constituting the porous fine particles. Moreover, by making the shape of hydroxyapatite spherical or irregularly shaped, it is possible to obtain porous particles that selectively adsorb more unsaturated fatty acids with less roughness on the skin and excellent usability.
本発明の有機高分子合成樹脂からなる多孔性粒子は、合成樹脂モノマーの溶液中にハイドロキシアパタイト粒子を分散させた後、重合反応、多孔質化反応、粒子形成の各工程を平行してあるいは単独で行うことによって得ることができる。
以下には、合成樹脂としてアクリレートを例示して、本発明の有機高分子合成樹脂からなる多孔性粒子であって、空隙率5〜50%、孔の直径が5〜5,000nm、粒子の平均粒径が1〜20μm及び多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合していることを特徴とする多孔性粒子の調製方法を説明する。本発明は、これに制限されるものではなく、適宜目的にあわせて必要な態様を常法に準じて実施できる。
The porous particles made of the organic polymer synthetic resin of the present invention are prepared by dispersing hydroxyapatite particles in a synthetic resin monomer solution, and then performing each step of polymerization reaction, porosification reaction, and particle formation in parallel or independently. Can be obtained by doing
In the following, acrylate is exemplified as the synthetic resin, and the porous particles are composed of the organic polymer synthetic resin of the present invention, the porosity is 5 to 50%, the pore diameter is 5 to 5,000 nm, and the average of the particles Porous, characterized in that a part of hydroxyapatite particles having an average particle diameter of 0.1 to 1 μm are embedded in the surface of the resin constituting the fine particles having a particle diameter of 1 to 20 μm and embedded therein. A method for preparing the particles will be described. The present invention is not limited to this, and necessary embodiments can be carried out according to conventional methods according to the purpose.
アクリレート樹脂は、アルキル(メタ)アクリレート50〜99.9重量%、分子内に2個以上のビニル基を有する多官能性モノマー0.1〜30重量%及びその他の共重合性モノマー0〜49.9重量%からなるモノマー、及び、ハイドロキシアパタイト粒子の混合物を分散安定剤、多孔質化剤の存在下に共重合させながら、粒状化工程に付することにより得られる。アルキル(メタ)アクリレートとしては、メチル(メタ)アクリレート、エチル(メタ)アクリレート、プロピル(メタ)アクリレート、ブチル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、イソノニル(メタ)アクリレート等アルキル基の炭素数が1〜10のものが好ましい。アルキル基の炭素数が10より大きいと下記に説明する懸濁法等によって粒子を合成した場合に球状の粒子が得られにくい。 The acrylate resin is composed of 50 to 99.9% by weight of alkyl (meth) acrylate, 0.1 to 30% by weight of a polyfunctional monomer having two or more vinyl groups in the molecule, and 0 to 49. It is obtained by subjecting a mixture of 9% by weight of monomer and hydroxyapatite particles to a granulating step while copolymerizing in the presence of a dispersion stabilizer and a porosifying agent. As alkyl (meth) acrylate, methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, butyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, isononyl (meth) Those having 1 to 10 carbon atoms in the alkyl group such as acrylate are preferred. When the alkyl group has more than 10 carbon atoms, it is difficult to obtain spherical particles when the particles are synthesized by the suspension method described below.
本発明の有機高分子合成樹脂からなる多孔性粒子であって、空隙率5〜50%、孔の直径が5〜5,000nm、粒子の平均粒径が1〜20μm及び多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合している多孔性粒子の合成にあたっては、乳化重合、懸濁重合、分散重合等の方法が用いられる。好ましくは、ハイドロキシアパタイトをモノマー溶液に添加して懸濁重合を行う。
懸濁重合は粒子形状を安定させるとともに、ハイドロキシアパタイトが多孔性粒子表面に均一に配置された製品を得ることができる。
懸濁重合は、先に述べたモノマー混合物、分散安定剤、界面活性剤、油溶性ラジカル重合開始剤、多孔質化剤等を用いて行う。
Porous particles made of the organic polymer synthetic resin of the present invention, having a porosity of 5 to 50%, a pore diameter of 5 to 5,000 nm, and an average particle size of 1 to 20 μm and constituting porous fine particles In the synthesis of porous particles bonded with a portion of hydroxyapatite particles having an average particle size of 0.1 to 1 μm embedded on the surface of the resin, methods such as emulsion polymerization, suspension polymerization, and dispersion polymerization are used. Is used. Preferably, suspension polymerization is performed by adding hydroxyapatite to the monomer solution.
Suspension polymerization can stabilize the particle shape and can provide a product in which hydroxyapatite is uniformly arranged on the surface of the porous particles.
Suspension polymerization is performed using the monomer mixture, dispersion stabilizer, surfactant, oil-soluble radical polymerization initiator, porosifying agent, and the like described above.
油溶性のラジカル重合開始剤及び多孔質化剤は、先に述べたモノマー混合物に予め溶解又は、分散させておくことが望ましい。
前記のアルキルメタアクリレートを用いて調製を行う場合に用いる分子内に2個以上のビニル基を有する多官能性モノマーとしては、ジビニルベンゼン等の芳香族ジビニルモノマー、エチレングリコールジ(メタ)アクリレート、ブチレングリコールジ(メタ)アクリレート、ヘキサンジオールジ(メタ)アクリレート、トリメチロールプロパンジ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート等のアルカンポリオールポリ(メタ)アクリレート、アリル(メタ)アクリレート、ジアリルイタコネート等の異なる反応性のビニル基を有するモノマー、その他ウレタンジ(メタ)アクリレート、エポキシ(メタ)アクリレート等が挙げられる。その他の共重合性モノマーとしては、スチレン、ビニルトルエン、α−メチルスチレン等の芳香族ビニル、芳香族ビニリデン、アクリロニトリル、メタクリロニトリル等のシアン化ビニル、シアン化ビニリデン、ウレタン(メタ)アクリレート等が挙げられる。
It is desirable that the oil-soluble radical polymerization initiator and the porosifying agent are previously dissolved or dispersed in the monomer mixture described above.
Examples of the polyfunctional monomer having two or more vinyl groups in the molecule used in the preparation using the alkyl methacrylate include aromatic divinyl monomers such as divinylbenzene, ethylene glycol di (meth) acrylate, butylene Alkane polyols such as glycol di (meth) acrylate, hexanediol di (meth) acrylate, trimethylolpropane di (meth) acrylate, trimethylolpropane tri (meth) acrylate, allyl (meth) acrylate, diallyl itaco Examples thereof include monomers having different reactive vinyl groups such as nates, other urethane di (meth) acrylates, and epoxy (meth) acrylates. Other copolymerizable monomers include aromatic vinyl such as styrene, vinyl toluene, α-methylstyrene, vinyl cyanide such as aromatic vinylidene, acrylonitrile, methacrylonitrile, vinylidene cyanide, urethane (meth) acrylate, etc. Can be mentioned.
また、この場合、官能基を持ったモノマーを共重合させることもできる。たとえば、グリシジルメタクリレート等のエポキシ基を持つモノマー、アクリル酸、メタクリル酸、マレイン酸、イタコン酸等のカルボキシル基を持つモノマー、2−ハイドロキシエチル(メタ)アクリレート等の水酸基を持つモノマー、ジエチルアミノエチル(メタ)アクリレート等のアミノ基を持つモノマー等が挙げられる。
分子内に2個以上のビニル基を有する多官能性モノマーとしては、トリメチロールプロパントリ(メタ)アクリレートを用いることが望ましい。
In this case, a monomer having a functional group can also be copolymerized. For example, monomers having an epoxy group such as glycidyl methacrylate, monomers having a carboxyl group such as acrylic acid, methacrylic acid, maleic acid and itaconic acid, monomers having a hydroxyl group such as 2-hydroxyethyl (meth) acrylate, diethylaminoethyl (meta ) Monomers having an amino group such as acrylate.
It is desirable to use trimethylolpropane tri (meth) acrylate as the polyfunctional monomer having two or more vinyl groups in the molecule.
前記の分散安定剤としては、ゼラチン、メチルセルロース、ハイドロキシエチルセルロース、ハイドロキシプロピルセルロース、カルボキシメチルセルロース、ポリエチレングリコール、ポリアクリルアミド、ポリアクリル酸、ポリアクリル酸塩、アルギン酸ナトリウム、ポリビニルアルコールの部分ケン化物等の水溶性高分子、酸化チタン、炭酸カルシウム、二酸化珪素等の無機物などが用いられる。また、これらの分散安定剤は、一種類又は二種類以上を使用できる。 Examples of the dispersion stabilizer include water-soluble gelatin, methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, polyethylene glycol, polyacrylamide, polyacrylic acid, polyacrylic acid salt, sodium alginate, and partially saponified products of polyvinyl alcohol. Polymers, inorganic substances such as titanium oxide, calcium carbonate, silicon dioxide and the like are used. These dispersion stabilizers can be used alone or in combination of two or more.
界面活性剤としては、ドデシルベンゼンスルホン酸ナトリウム、ジアルキルスルホコハク酸エステルナトリウム、ラウリル硫酸ナトリウム等のアニオン界面活性剤、ポリエチレングリコールノニルフェニルエーテル等のノニオン界面活性剤等が用いられる。また、これらの界面活性剤は、一種類又は二種類以上を使用できる。 As the surfactant, anionic surfactants such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinate and sodium lauryl sulfate, and nonionic surfactants such as polyethylene glycol nonylphenyl ether are used. These surfactants can be used alone or in combination of two or more.
油溶性ラジカル重合開始剤としては、ベンゾイルパーオキサイド、O−メトキシベンゾイルパーオキサイド、O−クロロベンゾイルパーオキサイド、ラウロイルパーオキサイド、クメンハイドロパーオキサイド等の有機過酸化物、2,2′−アゾビスイソブチロニトリル、2,2′−アゾビス−2,4−ジメチルバレロニトリル等のアゾ系化合物等が用いられる。また、これらの油溶性ラジカル重合開始剤は、一種類又は二種類以上を使用できる。 Examples of the oil-soluble radical polymerization initiator include organic peroxides such as benzoyl peroxide, O-methoxybenzoyl peroxide, O-chlorobenzoyl peroxide, lauroyl peroxide, cumene hydroperoxide, and 2,2′-azobisiso An azo compound such as butyronitrile, 2,2'-azobis-2,4-dimethylvaleronitrile, or the like is used. Moreover, these oil-soluble radical polymerization initiators can use one type or two or more types.
多孔質化剤は有機高分子架橋粒子を多孔質化する物質であり、いくつかの種類のものを適宜選択することができる。そのうちの1つとして、たとえばトルエン、イソオクタン、メチルイソブチルケトン等のように、モノマー混合物には溶解するが、その重合後のポリマーには溶解しない溶剤があげられる。この場合、溶剤の使用量はモノマー混合物100重量部に対し20〜200重量部程度である。
用いた多孔質化剤は、粒子の乾燥工程で除去され、該溶剤が除去された部分が細孔となる。さらに別の多孔質化剤として、たとえばポリ(メタ)アクリル酸アルキル等のように、モノマー混合物に溶解する直鎖状のポリマーが用いられる。この場合の直鎖状ポリマーの使用量はモノマー混合物100重量部に対し1〜10重量部程度であり、先に述べたモノマー混合物が重合を進めて行く過程において、溶解させておいた直鎖状のポリマーと相分離を起こし、粒子が多孔質化する。用いられる直鎖状のポリマーの種類は特に制限はないが、ポリマーの種類により、細孔の形や大きさが異なってくる。これらの表面処理多孔質球状粉末を得る多孔質化剤は、一種類又は二種類以上を使用できる。
粒子の形成は、前記混合溶液に添加する各添加物の種類、添加量、攪拌速度によって異なってくる。所望する大きさの粒子を得るためには攪拌速度を慎重に制御する必要があるが、目的とする樹脂や粒子径にあわせて最適な状態を適宜選択し、決定することができる。
The porosifying agent is a substance that makes the organic polymer crosslinked particles porous, and several types can be appropriately selected. One of them is a solvent that dissolves in the monomer mixture but does not dissolve in the polymer after polymerization, such as toluene, isooctane, methyl isobutyl ketone, and the like. In this case, the amount of the solvent used is about 20 to 200 parts by weight with respect to 100 parts by weight of the monomer mixture.
The used porosifying agent is removed in the particle drying step, and the portions where the solvent is removed become pores. As another porosifying agent, for example, a linear polymer that dissolves in the monomer mixture, such as alkyl poly (meth) acrylate, is used. The amount of the linear polymer used in this case is about 1 to 10 parts by weight with respect to 100 parts by weight of the monomer mixture, and the linear chain dissolved in the process of proceeding the polymerization of the monomer mixture described above. Cause phase separation with the polymer, and the particles become porous. The type of linear polymer used is not particularly limited, but the shape and size of the pores vary depending on the type of polymer. One kind or two or more kinds of porous agents for obtaining these surface-treated porous spherical powders can be used.
The formation of particles varies depending on the type, amount, and stirring speed of each additive added to the mixed solution. In order to obtain particles having a desired size, it is necessary to carefully control the stirring speed. However, an optimum state can be appropriately selected and determined according to the target resin and particle diameter.
上記の合成操作の過程で、ハイドロキシアパタイト粒子は、合成された多孔性樹脂内部には存在せず、樹脂の表面に配向し、ハイドロキシアパタイト粒子体の一部が樹脂に埋設された状態で強固に結合するのである。このような多孔性樹脂粒子については全く知られていなかった。
本発明の有機高分子合成樹脂からなる多孔性粒子であって、樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合していることを特徴とする多孔性粒子の平均粒子径は、好ましくは1〜20μm、特に好ましくは5〜10μmの範囲である。平均粒子径が1μmに満たないと、効果的にハイドロキシアパタイトが結合せず、また脂肪酸の吸着性も低下する。平均粒子径が20μmを超えると外用剤として用いた場合や、化粧料に用いたときに皮膚にザラつき感が生じ、良好な使用感が損なわれる場合がある。本発明の粒子における「球状」とは必ずしも真球状のものでなくてもよく、大きな突起のないほぼ球形に近い粒子状という意味である。また不定形とは、鋭利な先端角を有しない、多形状のものをいう。
In the process of the above synthesis, the hydroxyapatite particles are not present inside the synthesized porous resin, but are oriented on the surface of the resin, and the hydroxyapatite particles are firmly embedded in the resin. Combine. Such porous resin particles have not been known at all.
A porous particle comprising the organic polymer synthetic resin of the present invention, wherein a hydroxyapatite particle having an average particle size of 0.1 to 1 μm is firmly bonded to the surface of the resin. The average particle size is preferably in the range of 1 to 20 μm, particularly preferably 5 to 10 μm. When the average particle diameter is less than 1 μm, hydroxyapatite does not bind effectively, and the adsorptivity of fatty acids also decreases. When the average particle size exceeds 20 μm, when used as an external preparation or when used in cosmetics, the skin may have a rough feeling, and a good usability may be impaired. The “spherical shape” in the particles of the present invention does not necessarily have to be a spherical shape, and means a particle shape close to a spherical shape without a large protrusion. In addition, the irregular shape means a polymorphic shape having no sharp tip angle.
本発明の有機高分子合成樹脂からなる多孔性粒子であって、樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合していることを特徴とする多孔性粒子は、水銀圧入法で測定したとき空隙率5〜50%で、ハイドロキシアパタイトを酸溶解法によって溶解させた後、電子顕微鏡で観察したときに観察される孔の平均直径が5〜5,000nmの範囲であることが好ましい。なお、孔の平均直径は、電子顕微鏡観察を行った結果をもとに画像解析処理等で平均値を求めることができる。なお、孔の直径が5nm以下では所望する吸収効果が得られず、5000nm以上の場合は、粒子がもろく、また、所望するだけのハイドロキシアパタイトが結合しない。 Porous particles comprising the organic polymer synthetic resin of the present invention, wherein the hydroxyapatite particles having an average particle size of 0.1 to 1 μm are firmly bonded to the surface of the resin, In the range of 5 to 5,000 nm, the average diameter of the pores observed when observed with an electron microscope after dissolving hydroxyapatite by the acid dissolution method with a porosity of 5 to 50% when measured by mercury porosimetry It is preferable that The average diameter of the holes can be determined by image analysis processing or the like based on the result of observation with an electron microscope. If the pore diameter is 5 nm or less, the desired absorption effect cannot be obtained. If the pore diameter is 5000 nm or more, the particles are brittle and the desired amount of hydroxyapatite does not bind.
本発明の粒子には、球状の多孔性樹脂表面にハイドロキシアパタイトが結合して被覆している。このハイドロキシアパタイトの樹脂への結合率は、樹脂モノマーの重量に対して添加したハイドロキシアパタイトの重量を結合率又は被覆率として本発明においては定義する。上記に述べたとおり、樹脂の形成工程で添加したハイドロキシアパタイトは、実質的にすべて多孔性球状粒子の表面に配向する。従ってモノマー当たりのハイドロキシアパタイトの重量百分率は、本発明の多孔性粒子へのハイドロキシアパタイトの結合率として本発明においては定義する。また、このようにして定義した重量換算法で計算したときのハイドロキシアパタイトの結合率(被覆率)は、本発明においては10〜50重量%であることが好ましく、この範囲からはずれると十分な皮脂吸収性、特に不飽和脂肪酸の選択的吸着性が得られない。 The particles of the present invention are coated with hydroxyapatite bonded to the surface of a spherical porous resin. The bonding rate of the hydroxyapatite to the resin is defined in the present invention as the bonding rate or the covering rate based on the weight of the hydroxyapatite added to the weight of the resin monomer. As described above, the hydroxyapatite added in the resin forming step is substantially entirely oriented on the surface of the porous spherical particles. Accordingly, the percentage by weight of hydroxyapatite per monomer is defined in the present invention as the binding ratio of hydroxyapatite to the porous particles of the present invention. In addition, the hydroxyapatite binding rate (coverage) when calculated by the weight conversion method defined in this manner is preferably 10 to 50% by weight in the present invention. Absorbability, in particular, selective adsorption of unsaturated fatty acids cannot be obtained.
本発明の粒子は、ハイドロキシアパタイト粒子体の一部が樹脂に強固に結合していることが特徴である。従来技術で説明したように、従来の方法で得られたハイドロキシアパタイト粒子体が結合した球状の合成樹脂製粒子は、樹脂の表面にハイドロキシアパタイトが物理的な力で接着又は圧着しているか、あるいはバインディング剤を介して接着しているだけである。その結合状態は比較的ゆるやかなもので図2、又は図3のように樹脂表面にのみ結合しているだけである。これに対して、本発明の多孔性高分子樹脂からなる粒子においては、ハイドロキシアパタイト粒子体の一部が樹脂の内部に埋設した状態となっている。このため、樹脂とハイドロキシアパタイト粒子体は強固に結合している。この結合状態は、物理的衝撃では解離させることができない。一方従来の技術で調製したハイドロキシアパタイトによって被覆した粒子は、物理的衝撃でハイドロキシアパタイトが解離してしまう。このような結合状態の相違は、粒子をハンマーミルのような物理的衝撃を与える装置で粒子を処理した後、粒度分布を測定すると、本発明の粒子は多孔性粒子本来のもつ粒度分布を示すのに対して、従来技術で調製した粒子は、樹脂粒子の粒度と物理的衝撃により剥離脱落したハイドロキシアパタイトの粒度の、2峰性の分布を示すことから確認することができる。 The particles of the present invention are characterized in that a part of the hydroxyapatite particles are firmly bonded to the resin. As explained in the prior art, the spherical synthetic resin particles bonded with the hydroxyapatite particles obtained by the conventional method are bonded or pressure-bonded to the surface of the resin by physical force, or They are only bonded via a binding agent. The bonding state is relatively gentle and is only bonded to the resin surface as shown in FIG. 2 or FIG. On the other hand, in the particles made of the porous polymer resin of the present invention, a part of the hydroxyapatite particle body is embedded in the resin. For this reason, the resin and the hydroxyapatite particles are firmly bonded. This bonded state cannot be dissociated by physical impact. On the other hand, in the particles coated with hydroxyapatite prepared by the conventional technique, hydroxyapatite is dissociated by physical impact. The difference in the bonding state is that the particles of the present invention exhibit the particle size distribution inherent in the porous particles when the particle size distribution is measured after the particles are processed with a device that gives physical impact such as a hammer mill. On the other hand, the particles prepared by the conventional technique can be confirmed by showing a bimodal distribution of the particle size of the resin particles and the particle size of the hydroxyapatite peeled off due to physical impact.
また、ハイドロキシアパタイト粒子は、樹脂を構成するモノマーが架橋される過程で多孔性粒子の表面に配向する。従って樹脂とハイドロキシアパタイトは従来技術と異なった結合状態を呈する。すなわち、従来技術ではハイドロキシアパタイトは、樹脂表面と点で接することとなるが、本発明の場合には、樹脂表面にハイドロキシアパタイトが面で接する又は埋設状態で結合することとなる。この状態の相違は、粒子を例えば粒子の中心線を通る面で切断し、その断面を電子顕微鏡や高解像度の顕微鏡で観察したとき、樹脂とハイドロキシアパタイトの接触面が密着しているか、点で接触しているかで確認することができる。 Further, the hydroxyapatite particles are oriented on the surface of the porous particles in the process of crosslinking the monomers constituting the resin. Accordingly, the resin and hydroxyapatite exhibit a bonding state different from that of the prior art. That is, in the prior art, hydroxyapatite comes into contact with the resin surface at a point, but in the case of the present invention, hydroxyapatite comes into contact with the resin surface on the surface or bonds in an embedded state. The difference in this state is that the contact surface between the resin and the hydroxyapatite is in close contact when the particle is cut, for example, on a plane passing through the center line of the particle and the cross section is observed with an electron microscope or a high-resolution microscope. It can be confirmed by contact.
本発明の有機高分子合成樹脂からなる多孔性粒子であって、結合している個々のハイドロキシアパタイト粒子が樹脂に強固に結合していることを特徴とする多孔性粒子を皮膚外用剤として用いると、効果的に脂肪酸を吸着し、皮膚の炎症やニキビを抑制することができる。外用剤や化粧料への配合割合は、通常0.01〜30重量%、好ましくは0.1〜10重量%である。配合割合が0.01重量%に満たないと、十分な皮脂吸収性と不飽和脂肪酸吸着性が得られない。配合割合が30重量%を越えると、ざらつき感が生じ、良好な使用感が損なわれる。 Porous particles comprising the organic polymer synthetic resin of the present invention, wherein porous particles characterized in that individual bonded hydroxyapatite particles are firmly bonded to the resin are used as a skin external preparation. Can effectively adsorb fatty acids and suppress skin inflammation and acne. The compounding ratio to an external preparation and cosmetics is 0.01 to 30 weight% normally, Preferably it is 0.1 to 10 weight%. If the blending ratio is less than 0.01% by weight, sufficient sebum absorbability and unsaturated fatty acid adsorbability cannot be obtained. When the blending ratio exceeds 30% by weight, a rough feeling is generated and a good feeling in use is impaired.
本発明の有機高分子合成樹脂からなる多孔性粒子であって、多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体が強固に結合していることを特徴とする多孔性粒子は、すべての外用剤及び化粧料、特にメイクアップ化粧料やスキンケア化粧料に広く応用することが可能である。配合に当たっては、従来の顔料等の配合と同様の方法で外用剤や化粧料に配合できる。特に、このようにして提供される本発明の化粧料としては、例えばファンデーション、口紅、ほほ紅、アイライナー、アイシャドウ、アイブロー、まゆずみ、粉おしろい及びフェイスパウダーなどのメイクアップ化粧料や、顔や頭皮の皮脂をコントロールする為のローション、エッセンス、乳液、ジェル及びパウダーなどのスキンケア化粧料を挙げることができる。 Porous particles made of the organic polymer synthetic resin of the present invention, characterized in that hydroxyapatite particles having an average particle size of 0.1 to 1 μm are firmly bonded to the surface of the resin constituting the porous fine particles. The porous particles can be widely applied to all external preparations and cosmetics, particularly makeup cosmetics and skin care cosmetics. In blending, it can be blended into external preparations and cosmetics in the same manner as conventional pigment blending. In particular, the cosmetics of the present invention thus provided include makeup cosmetics such as foundations, lipsticks, cheeks, eyeliners, eye shadows, eyebrows, eyebrows, powdered and face powders, And skin care cosmetics such as lotions, essences, emulsions, gels and powders for controlling the sebum of the scalp.
また、本発明の有機高分子合成樹脂からなる多孔性粒子であって、空隙率5〜50%、粒子の平均粒径が1〜20μm及び多孔性微粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合していることを特徴とする多孔性粒子は多量の油分を吸収し、選択的に不飽和脂肪酸を吸着することができるので、化粧料に配合して所期の効果を発揮できることはもちろんのこと、安定剤等の目的と用途で、外用剤や医薬品、食品、塗料など幅広い分野において応用することができ、さらに不飽和脂肪酸選択吸着剤として応用できる。 Further, the porous particles are composed of the organic polymer synthetic resin of the present invention, and the porosity is 5 to 50%, the average particle diameter is 1 to 20 μm, and the average particle diameter is 0 on the surface of the resin constituting the porous fine particles. Porous particles characterized by being bonded in a state where a part of .1-1 μm hydroxyapatite particles are embedded can absorb a large amount of oil and selectively adsorb unsaturated fatty acids. Therefore, it can be used in cosmetics and can be used in a wide range of fields such as external preparations, pharmaceuticals, foods, paints, etc. It can be applied as a fatty acid selective adsorbent.
本発明の外用剤、化粧料には、植物油のような油脂類、高級脂肪酸、高級アルコール、シリコン、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、非イオン界面活性剤、防腐剤、糖類、金属イオン封鎖剤、水溶性高分子のような高分子、増粘剤、粉体成分、紫外線吸収剤、紫外線遮断剤、ヒアルロン酸のような保湿剤、香料、pH調整剤、等を含有させることができる。ビタミン類、皮膚賦活剤、血行促進剤、常在菌コントロール剤、活性酸素消去剤、抗炎症剤、美白剤、殺菌剤等の他の薬効成分、生理活性成分を含有させることもできる。 External preparations and cosmetics of the present invention include fats and oils such as vegetable oils, higher fatty acids, higher alcohols, silicon, anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, preservatives, Contains sugars, sequestering agents, polymers such as water-soluble polymers, thickeners, powder components, UV absorbers, UV blockers, moisturizers such as hyaluronic acid, fragrances, pH adjusters, etc. Can be made. Vitamins, skin activators, blood circulation promoters, resident bacteria control agents, active oxygen scavengers, anti-inflammatory agents, whitening agents, bactericides, and other medicinal and physiologically active components can also be included.
油脂類として、例えば、ツバキ油、月見草油、マカデミアナッツ油、オリーブ油、ナタネ油、トウモロコシ油、ゴマ油、ホホバ油、胚芽油、小麦胚芽油、トリオクタン酸グリセリン、等の液体油脂、カカオ脂、ヤシ油、硬化ヤシ油、パーム油、パーム核油、モクロウ、モクロウ核油、硬化油、硬化ヒマシ油等の固体油脂、ミツロウ、キャンデリラロウ、綿ロウ、ヌカロウ、ラノリン、酢酸ラノリン、液状ラノリン、サトウキビロウ等のロウ類が挙げられる。
炭化水素類として、例えば、流動パラフィン、スクワレン、スクワラン、マイクロクリスタリンワックス等が挙げられる。
高級脂肪酸として、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、リノレン酸、ドコサヘキサエン酸(DHA)、エイコサペンタエン酸(EPA)等が挙げられる。
As fats and oils, for example, camellia oil, evening primrose oil, macadamia nut oil, olive oil, rapeseed oil, corn oil, sesame oil, jojoba oil, germ oil, wheat germ oil, glycerin trioctanoate, etc., cocoa butter, coconut oil, Hardened coconut oil, palm oil, palm kernel oil, owl, owl kernel oil, hardened oil, hardened castor oil and other solid fats, beeswax, candelilla wax, cotton wax, nutca wax, lanolin, lanolin acetate, liquid lanolin, sugarcane wax, etc. Waxes.
Examples of hydrocarbons include liquid paraffin, squalene, squalane, and microcrystalline wax.
Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and the like.
高級アルコールとして、例えば、ラウリルアルコール、ステアリルアルコール、セチルアルコール、セトステアリルアルコール等の直鎖アルコール、モノステアリルグリセリンエーテル、ラノリンアルコール、コレステロール、フィトステロール、オクチルドデカノール等の分枝鎖アルコール等が挙げられる。
シリコンとして、例えば、鎖状ポリシロキサンのジメチルポリシロキサン、メチルフェニルポリシロキサン等、環状ポリシロキサンのデカメチルシクロペンタシロキサン等が挙げられる。
Examples of the higher alcohol include linear alcohols such as lauryl alcohol, stearyl alcohol, cetyl alcohol, and cetostearyl alcohol, and branched chain alcohols such as monostearyl glycerol ether, lanolin alcohol, cholesterol, phytosterol, and octyldodecanol.
Examples of silicon include linear polysiloxanes such as dimethylpolysiloxane and methylphenylpolysiloxane, and cyclic polysiloxanes such as decamethylcyclopentasiloxane.
アニオン界面活性剤として、例えば、ラウリン酸ナトリウム等の脂肪酸塩、ラウリル硫酸ナトリウム等の高級アルキル硫酸エステル塩、POEラウリル硫酸トリエタノールアミン等のアルキルエーテル硫酸エステル塩、N−アシルサルコシン酸、スルホコハク酸塩、N−アシルアミノ酸塩等が挙げられる。
カチオン界面活性剤として、例えば、塩化ステアリルトリメチルアンモニウム等のアルキルトリメチルアンモニウム塩、塩化ベンザルコニウム、塩化ベンゼトニウム等が挙げられる。
両性界面活性剤として、例えば、アルキルベタイン、アミドベタイン等のベタイン系界面活性剤等が挙げられる。
非イオン界面活性剤として、例えば、ソルビタンモノオレエート等のソルビタン脂肪酸エステル類、硬化ヒマシ油誘導体が挙げられる。
Examples of the anionic surfactant include fatty acid salts such as sodium laurate, higher alkyl sulfates such as sodium lauryl sulfate, alkyl ether sulfates such as POE lauryl sulfate triethanolamine, N-acyl sarcosine acid, sulfosuccinate , N-acyl amino acid salts and the like.
Examples of the cationic surfactant include alkyltrimethylammonium salts such as stearyltrimethylammonium chloride, benzalkonium chloride, and benzethonium chloride.
Examples of amphoteric surfactants include betaine surfactants such as alkyl betaines and amide betaines.
Examples of nonionic surfactants include sorbitan fatty acid esters such as sorbitan monooleate and hydrogenated castor oil derivatives.
防腐剤として、例えば、メチルパラベン、エチルパラベン等を挙げることができる。
金属イオン封鎖剤として、例えば、エチレンジアミン四酢酸二ナトリウム、エデト酸、エデト酸ナトリウム塩等のエデト酸塩を挙げることができる。
高分子として、例えば、アラビアゴム、トラガカントガム、ガラクタン、グアーガム、カラギーナン、ペクチン、寒天、クインスシード、デキストラン、プルラン、カルボキシメチルデンプン、コラーゲン、カゼイン、ゼラチン、メチルセルロース、メチルハイドロキシプロピルセルロース、ハイドロキシエチルセルロース、カルボキシメチルセルロースナトリウム(CMC)、アルギン酸ナトリウム、カルボキシビニルポリマー(CARBOPOL等)等のビニル系高分子、等を挙げることができる。
増粘剤として、カラギーナン、トラガカントガム、クインスシード、カゼイン、デキストリン、ゼラチン、CMC、ハイドロキシエチルセルロース、ハイドロキシプロピルセルロース、グアーガム、キサンタンガム、ベントナイト等を挙げることができる。
粉末成分として、例えば、タルク、カオリン、雲母、シリカ、ゼオライト、ポリエチレン粉末、ポリスチレン粉末、セルロース粉末、無機白色顔料、無機赤色系顔料、酸化チタンコーテッドマイカ、酸化チタンコーテッドタルク、着色酸化チタンコーテッドマイカ等のパール顔料、赤色201号、赤色202号等の有機顔料を挙げることができる。
Examples of preservatives include methyl paraben and ethyl paraben.
Examples of the sequestering agent include edetates such as disodium ethylenediaminetetraacetate, edetic acid, and sodium edetate.
Examples of polymers include gum arabic, gum tragacanth, galactan, guar gum, carrageenan, pectin, agar, quince seed, dextran, pullulan, carboxymethyl starch, collagen, casein, gelatin, methylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, carboxymethylcellulose Examples thereof include vinyl polymers such as sodium (CMC), sodium alginate, and carboxyvinyl polymer (such as CARBOPOL).
Examples of the thickener include carrageenan, tragacanth gum, quince seed, casein, dextrin, gelatin, CMC, hydroxyethyl cellulose, hydroxypropyl cellulose, guar gum, xanthan gum, bentonite and the like.
Examples of powder components include talc, kaolin, mica, silica, zeolite, polyethylene powder, polystyrene powder, cellulose powder, inorganic white pigment, inorganic red pigment, titanium oxide coated mica, titanium oxide coated talc, and colored titanium oxide coated mica. And organic pigments such as Red No. 201 and Red No. 202.
紫外線吸収剤として、例えば、パラアミノ安息香酸、サリチル酸フェニル、パラメトキシケイ皮酸イソプロピル、パラメトキシケイ皮酸オクチル、2,4−ジハイドロキシベンゾフェノン、等を挙げることができる。
紫外線遮断剤として、例えば、酸化チタン、タルク、カルミン、ベントナイト、カオリン、酸化亜鉛等を挙げることができる。
保湿剤として、例えば、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、1,2−ペンタンジオール、グリセリン、ジグリセリン、ポリグリセリン、キシリトール、マルチトール、マルトース、ソルビトール、ブドウ糖、果糖、コンドロイチン硫酸ナトリウム、ヒアルロン酸ナトリウム、乳酸ナトリウム、ピロリドンカルボン酸、シクロデキストリン等が挙げられる。
Examples of the ultraviolet absorber include paraaminobenzoic acid, phenyl salicylate, isopropyl paramethoxycinnamate, octyl paramethoxycinnamate, 2,4-dihydroxybenzophenone, and the like.
Examples of the ultraviolet blocking agent include titanium oxide, talc, carmine, bentonite, kaolin, and zinc oxide.
Examples of humectants include polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, 1,2-pentanediol, glycerin, diglycerin, polyglycerin, xylitol, maltitol, maltose, sorbitol, glucose, fructose. , Sodium chondroitin sulfate, sodium hyaluronate, sodium lactate, pyrrolidone carboxylic acid, cyclodextrin and the like.
薬効成分として、例えば、ビタミンA油、レチノール等のビタミンA類、リボフラビン等のビタミンB2類、ピリドキシン塩酸塩等のB6類、L−アスコルビン酸、L−アスコルビン酸リン酸エステル、L−アスコルビン酸モノパルミチン酸エステル、L−アスコルビン酸ジパルミチン酸エステル、L−アスコルビン酸−2−グルコシド等のビタミンC類、パントテン酸カルシウム等のパントテン酸類、ビタミンD2、コレカルシフェロール等のビタミンD類、α−トコフェロール、酢酸トコフェロール、ニコチン酸DL−α−トコフェロール等のビタミンE類等のビタミン類を挙げることができる。
プラセンタエキス、グルタチオン、ユキノシタ抽出物等の美白剤、ローヤルゼリー、ぶなの木エキス等の皮膚賦活剤、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、カフェイン、タンニン酸、γ−オリザノール等の血行促進剤、グリチルリチン酸誘導体、グリチルレチン酸誘導体、アズレン等の消炎剤、アルギニン、セリン、ロイシン、トリプトファン等のアミノ酸類、常在菌コントロール剤のマルトースショ糖縮合物、塩化リゾチーム等を挙げることができる。
さらに、カミツレエキス、パセリエキス、ワイン酵母エキス、グレープフルーツエキス、スイカズラエキス、コメエキス、ブドウエキス、ホップエキス、コメヌカエキス、ビワエキス、オウバクエキス、ヨクイニンエキス、センブリエキス、メリロートエキス、バーチエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、トウガラシエキス、レモンエキス、ゲンチアナエキス、シソエキス、アロエエキス、ローズマリーエキス、セージエキス、タイムエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、ニンジンエキス、マロニエエキス、ハマメリスエキス、クワエキス等の各種抽出物を挙げることができる。
As medicinal components, for example, vitamin A oil, vitamin A such as retinol, vitamin B 2 such as riboflavin, B 6 such as pyridoxine hydrochloride, L- ascorbic acid, L- ascorbic acid phosphoric acid ester, L- ascorbic Vitamin C such as acid monopalmitate, L-ascorbic acid dipalmitate, L-ascorbic acid-2-glucoside, pantothenic acid such as calcium pantothenate, vitamin D such as vitamin D 2 and cholecalciferol, Vitamins such as vitamin E such as α-tocopherol, tocopherol acetate and DL-α-tocopherol nicotinate can be mentioned.
Whitening agents such as placenta extract, glutathione, and yukinoshita extract, skin activators such as royal jelly, beech tree extract, blood circulation promoters such as capsaicin, gingeron, cantalis tincture, ictamol, caffeine, tannic acid, γ-oryzanol, Examples include glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, anti-inflammatory agents such as azulene, amino acids such as arginine, serine, leucine, and tryptophan, maltose sucrose condensates of resident bacteria control agents, and lysozyme chloride.
In addition, chamomile extract, parsley extract, wine yeast extract, grapefruit extract, honeysuckle extract, rice extract, grape extract, hop extract, rice bran extract, loquat extract, buckwheat extract, yakuinin extract, assembly extract, merirot extract, birch extract, licorice extract, peony extract , Savanna extract, loofah extract, capsicum extract, lemon extract, gentian extract, perilla extract, aloe extract, rosemary extract, sage extract, thyme extract, tea extract, seaweed extract, cucumber extract, carrot extract, carrot extract, maronier extract, Examples include various extracts such as chammel extract and mulberry extract.
また本発明の空隙率5〜50%、粒子の平均粒径が1〜20μmの有機高分子合成樹脂からなる多孔性粒子であって、多孔性粒子を構成する樹脂の表面に平均粒子径0.1〜1μmのハイドロキシアパタイト粒子が結合していることを特徴とする多孔性粒子は、吸着特性が優れていること、及び多孔性であることからクロマトグラフィの担体として分子篩や吸着剤としても使用することが可能である。
以下に本発明を、実施例及び比較例に基づき、さらに具体的に説明するが、本発明はこれらにより限定されるものではない。
Further, the present invention is a porous particle made of an organic polymer synthetic resin having a porosity of 5 to 50% and an average particle diameter of 1 to 20 μm, and having an average particle diameter of 0.00 on the surface of the resin constituting the porous particle. Porous particles characterized by binding of 1 to 1 μm hydroxyapatite particles have excellent adsorption characteristics and are porous, so they can be used as molecular sieves and adsorbents as chromatographic carriers. Is possible.
Hereinafter, the present invention will be described more specifically based on Examples and Comparative Examples, but the present invention is not limited thereto.
[製造例1]
本発明のハイドロキシアパタイトが結合した有機高分子合成樹脂からなる多孔性粒子の調製
水555gにポリビニルアルコール(クラレポバール205、(株)クラレ製)5gを溶解させた水溶液に、平均粒子径0.2μmハイドロキシアパタイト粉末50g、メチル(メタ)アクリレート190g、トリメチロールプロパントリ(メタ)アクリレート10g、ラウロイルパーオキサイド1g、メチルイソブチルケトン100gからなる混合液を加え、これをホモミキサーを用いて撹拌し、モノマー混合液の分散液を調製した。この際ホモミキサーの撹拌翼の回転数を3,000rpmとして撹拌し、分散溶液を調製した。この分散溶液を撹拌機、還流冷却器、温度計、窒素吹き込み口を備えた4つ口フラスコに移し、窒素気流下で回転速度100rpmで撹拌しながら、60℃に昇温し、そのまま3時間懸濁重合反応させた。
得られた粒子の懸濁液を室温まで冷却後、粒子を濾別水洗し、フィルター上に回収したケーキを110℃で24時間乾燥させて、平均粒径8μmのハイドロキシアパタイト粒子体の一部が埋設された状態で結合している多孔性粒子238gを得た。得られた本発明の多孔性粒子の電子顕微鏡写真を図1に示した。この粒子の孔径は約100nmであった。またハイドロキシアパタイト被覆率は23.2%であった。
[Production Example 1]
Preparation of Porous Particles Composed of Organic Polymer Synthetic Resin Bonded with Hydroxyapatite of the Present Invention An average particle diameter of 0.2 μm in an aqueous solution in which 5 g of polyvinyl alcohol (Kuraray Poval 205, Kuraray Co., Ltd.) is dissolved in 555 g of water A mixed liquid consisting of 50 g of hydroxyapatite powder, 190 g of methyl (meth) acrylate, 10 g of trimethylolpropane tri (meth) acrylate, 1 g of lauroyl peroxide and 100 g of methyl isobutyl ketone is added, and this is stirred using a homomixer and mixed with monomers. A liquid dispersion was prepared. At this time, the homogenizer was stirred at a rotation speed of the stirring blade of 3,000 rpm to prepare a dispersion solution. This dispersed solution was transferred to a four-necked flask equipped with a stirrer, reflux condenser, thermometer, and nitrogen inlet, heated to 60 ° C. with stirring at a rotational speed of 100 rpm under a nitrogen stream, and suspended for 3 hours. The suspension polymerization reaction was performed.
After cooling the resulting particle suspension to room temperature, the particles were filtered and washed with water, and the cake collected on the filter was dried at 110 ° C. for 24 hours to obtain a portion of the hydroxyapatite particles having an average particle size of 8 μm. 238 g of porous particles bonded in the embedded state were obtained. An electron micrograph of the obtained porous particles of the present invention is shown in FIG. The pore diameter of this particle was about 100 nm. The hydroxyapatite coverage was 23.2%.
[比較製造例1]
非多孔性粒子の製造例
樹脂粒子の孔の有無が粒子の吸油性や脂肪酸の吸収に及ぼす効果を確認するため、非孔性粒子を調製した。すなわち多孔質化剤は無添加にし、以下は同一条件としてハイドロキシアパタイト粒子体の一部が埋設された状態の粒子を調製した。調製方法は以下のとおりである。
水555gにポリビニルアルコール(クラレポバール205(株)クラレ製)5gを溶解させた水溶液に、平均粒子径0.2μmハイドロキシアパタイト粉末120g、メチル(メタ)アクリレート190g、トリメチロールプロパントリ(メタ)アクリレート10g、ラウロイルパーオキサイド1gの混合液を加えた。これをホモミキサーを用いて撹拌し、モノマー混合液の分散溶液を調製した。この際ホモミキサーの撹拌の強さを製造例1と同様に3,000rpmとして撹拌し、分散溶液を調製した。この分散溶液を撹拌機、還流冷却器、温度計、窒素吹き込み口を備えた4つ口フラスコに移し、窒素気流下で撹拌しながら、60℃に昇温し、そのまま3時間懸濁重合反応させた。得られた懸濁液を室温まで冷却後、濾別水洗し、フィルター上に回収したケーキを110℃で24時間乾燥させて、平均粒径8μm、ハイドロキシアパタイト被覆率15.8%の非多孔性粒子を得た。
得られた非多孔性粒子の電子顕微鏡写真を図2に示した。
[Comparative Production Example 1]
Production Example of Nonporous Particles In order to confirm the effect of the presence or absence of pores in the resin particles on the oil absorbency of the particles and the absorption of fatty acids, nonporous particles were prepared. That is, no porous agent was added, and the following conditions were used under the same conditions to prepare particles in which a portion of the hydroxyapatite particles were embedded. The preparation method is as follows.
In an aqueous solution in which 5 g of polyvinyl alcohol (made by Kuraray Poval 205 Co., Ltd.) was dissolved in 555 g of water, 120 g of hydroxyapatite powder having an average particle size of 0.2 μm, 190 g of methyl (meth) acrylate, 10 g of trimethylolpropane tri (meth) acrylate A mixed solution of 1 g of lauroyl peroxide was added. This was stirred using a homomixer to prepare a dispersion solution of the monomer mixture. At this time, the stirring strength of the homomixer was set to 3,000 rpm in the same manner as in Production Example 1 to prepare a dispersion solution. This dispersion was transferred to a four-necked flask equipped with a stirrer, reflux condenser, thermometer, and nitrogen blowing port, heated to 60 ° C. while stirring under a nitrogen stream, and allowed to undergo a suspension polymerization reaction for 3 hours. It was. The obtained suspension was cooled to room temperature, filtered and washed with water, and the cake collected on the filter was dried at 110 ° C. for 24 hours to obtain a nonporous material having an average particle diameter of 8 μm and a hydroxyapatite coverage of 15.8%. Particles were obtained.
An electron micrograph of the obtained non-porous particles is shown in FIG.
[比較製造例2]
メカノケミカル法による表面処理多孔質球状粉末の調製
ハイドロキシアパタイトの結合状態が脂肪酸の吸収に及ぼす効果を確認するため、従来技術によりハイドロキシアパタイトを粒子表面に結合させた粒子を調製した。
水555gにポリビニルアルコール(クラレポバール205、(株)クラレ製)5gを溶解させた水溶液に、メチル(メタ)アクリレート190g、トリメチロールプロパントリ(メタ)アクリレート10g、ラウロイルパーオキサイド1g、メチルイソブチルケトン100gからなる混合液を加え、これをホモミキサーを用いて撹拌し、モノマー混合液の分散液を調製した。この際ホモミキサーの撹拌翼の回転数を3,000rpmとして撹拌し、分散溶液を調製した。この分散溶液を撹拌機、還流冷却器、温度計、窒素吹き込み口を備えた4つ口フラスコに移し、窒素気流下で撹拌しながら、60℃に昇温し、そのまま3時間懸濁重合反応させた。得られた懸濁液を室温まで冷却後、濾別水洗し、フィルターケーキを110℃で24時間乾燥させて、平均粒子径8μmの多孔質球状粉末を得た。得られた多孔質球状粉末を60部に対して平均粒子径0.2μmハイドロキシアパタイト粉末を40部を混合しヘンシェルミキサーで10分間混合し、その後の回転式ボールミルで24時間混合し、目的とする粒子を得た。
得られた従来技術の粒子の電子顕微鏡写真を図3に示す。
[Comparative Production Example 2]
Preparation of surface-treated porous spherical powder by mechanochemical method In order to confirm the effect of the binding state of hydroxyapatite on the absorption of fatty acids, particles in which hydroxyapatite was bonded to the particle surface were prepared by conventional techniques.
In an aqueous solution obtained by dissolving 5 g of polyvinyl alcohol (Kuraray Poval 205, manufactured by Kuraray Co., Ltd.) in 555 g of water, 190 g of methyl (meth) acrylate, 10 g of trimethylolpropane tri (meth) acrylate, 1 g of lauroyl peroxide, 100 g of methyl isobutyl ketone A mixed solution consisting of the following was added, and this was stirred using a homomixer to prepare a dispersion of the monomer mixed solution. At this time, the homogenizer was stirred at a rotation speed of the stirring blade of 3,000 rpm to prepare a dispersion solution. This dispersion was transferred to a four-necked flask equipped with a stirrer, reflux condenser, thermometer, and nitrogen blowing port, heated to 60 ° C. while stirring under a nitrogen stream, and allowed to undergo a suspension polymerization reaction for 3 hours. It was. The obtained suspension was cooled to room temperature, filtered and washed with water, and the filter cake was dried at 110 ° C. for 24 hours to obtain a porous spherical powder having an average particle size of 8 μm. 60 parts of the obtained porous spherical powder is mixed with 40 parts of hydroxyapatite powder having an average particle size of 0.2 μm, mixed with a Henschel mixer for 10 minutes, and then mixed with a rotary ball mill for 24 hours. Particles were obtained.
An electron micrograph of the resulting prior art particles is shown in FIG.
図1、図2、図3から明らかなように、本発明による粒子は、ハイドロキシアパタイトが密着して結合しているのに対して、従来技術に基づいて得た粒子は、表面に凹凸が出現したり(図2)、ハイドロキシアパタイトが脱落したりする現象が観察された。 As is apparent from FIGS. 1, 2 and 3, the particles according to the present invention have hydroxyapatite intimately bonded to each other, whereas particles obtained based on the conventional technique have irregularities on the surface. (FIG. 2), and a phenomenon in which hydroxyapatite falls off was observed.
[物性測定]
本発明の粒子(製造例1)、比較製造例1、比較製造例2で得られた粒子の粒子形状、平均粒子径、ハイドロキシアパタイトの被覆状態及び空隙率を測定した。測定結果を表1に示す。
平均粒子径は(μm)はコールターマルチサイダーII(コールター(株)製)により測定し、重量分布の算術径の値を採用した。
合成樹脂粒子に形成された孔の空隙率(%)は水銀圧入法より求めた。
またハイドロキシアパタイトの被覆状態は電子顕微鏡写真で観察し、結合状態に応じて○:未付着粒子がほとんどない、△:未付着粒子が少しある、×:未付着粒子が多数ありとした。
結果を下記表1に示す。
[Physical property measurement]
The particle shape, average particle size, hydroxyapatite coating state, and porosity of the particles of the present invention (Production Example 1), Comparative Production Example 1 and Comparative Production Example 2 were measured. The measurement results are shown in Table 1.
The average particle diameter (μm) was measured by Coulter Multisider II (manufactured by Coulter Co., Ltd.), and the value of the arithmetic diameter of the weight distribution was adopted.
The porosity (%) of the holes formed in the synthetic resin particles was determined by a mercury intrusion method.
Further, the coating state of hydroxyapatite was observed with an electron micrograph, and according to the bonding state, ◯: almost no unattached particles, Δ: some unattached particles, x: many unattached particles.
The results are shown in Table 1 below.
表1に示すように本発明の粒子は、粒子形状が多孔質球状で、平均粒子径が8.2μm、空隙率が25%であり、かつハイドロキシアパタイトの未付着粒子がほとんどない均一にハイドロキシアパタイトが被覆されているものが得られた。
さらに表面以外の部分にハイドロキシアパタイトが存在するかどうかを確認するために製造例1の粒子粉末をエポキシ樹脂中に分散して固めた後、樹脂を切断して粉末の割断面を図4のように透過型電子顕微鏡にて確認した。白い部分はハイドロキシアパタイトであり、球状粉末の周囲のみ均一な状態で被覆されていることが確認できた。
また、比較製造例2のメカノケミカル法による粒子と製造例1の本発明粒子について光学顕微鏡により観察した。アクリル樹脂プレートに「LOCTITE 多用途 プロユースタイプ (株)セメダイン」を適量塗布し、その上に比較製造例2のメカノケミカル法による粒子、製造例1の本発明粒子を平らに載せて十分に乾燥させる。その後ダイヤモンドカッターで水平方向に平らにカットし、その切片を光学顕微鏡で観察した。
その結果、比較製造例2の粒子は内部が多孔質になっており、表面(外周)も同じように凹凸があるのに比べて(図8)、製造例1の本発明粒子は同様に内部が多孔質になっているが表面(外周)が平らであり、表面のみ特に密にハイドロキシアパタイトが被覆されていることがわかる(図9)。
As shown in Table 1, the particles of the present invention have a porous spherical shape, an average particle size of 8.2 μm, a porosity of 25%, and uniform hydroxyapatite with almost no hydroxyapatite unattached particles. Was obtained.
Further, in order to confirm whether or not hydroxyapatite is present in a portion other than the surface, the particle powder of Production Example 1 was dispersed and hardened in an epoxy resin, and then the resin was cut and the fractured surface of the powder was as shown in FIG. Were confirmed with a transmission electron microscope. The white part was hydroxyapatite, and it was confirmed that only the periphery of the spherical powder was coated in a uniform state.
In addition, the mechanochemical method particles of Comparative Production Example 2 and the present invention particles of Production Example 1 were observed with an optical microscope. Appropriate amount of “LOCTITE Multipurpose Pro-use Type Co., Ltd.” is applied to the acrylic resin plate, and then the particles by the mechanochemical method of Comparative Production Example 2 and the present invention particles of Production Example 1 are placed flat on it and dried thoroughly. Let Thereafter, the sample was cut flat with a diamond cutter in the horizontal direction, and the section was observed with an optical microscope.
As a result, the particles of Comparative Production Example 2 are porous inside, and the surface (outer periphery) is similarly uneven (FIG. 8). Although it is porous, the surface (outer periphery) is flat, and it can be seen that the surface is particularly densely coated with hydroxyapatite (FIG. 9).
[ハイドロキシアパタイトの結合性確認試験]
製造例1、比較製造例1で得られた粒子をそれぞれ100gをハンマーミル(不二パウダル製)で3回粉砕した後、粒度分布をコールターマルチサイダーII(コールター(株)製)により測定した。
製造例1の粒子は1μm以下の粒子は全く存在せず、8〜9μmに集中している。(図5)。一方比較製造例1の粒子を同様に処理して粒度分布を測定したところ、粒子本来の粒度である10μmのピークとハイドロキシアパタイトの粒度である0.5μm付近のピークの2峰性の粒度分布を示した(図6)。これは比較製造例1の粒子は、物理的な衝撃によってハイドロキシアパタイトが剥離したためである。
[Hydroxyapatite binding confirmation test]
After 100 g of each of the particles obtained in Production Example 1 and Comparative Production Example 1 were pulverized 3 times with a hammer mill (Fuji Powder), the particle size distribution was measured with Coulter Multicider II (Coulter Co., Ltd.).
The particles of Production Example 1 have no particles of 1 μm or less and are concentrated at 8 to 9 μm. (FIG. 5). On the other hand, when the particle size distribution was measured by treating the particles of Comparative Production Example 1 in the same manner, the particle size distribution was bimodal, with the original particle size of 10 μm peak and the hydroxyapatite particle size of about 0.5 μm peak. Shown (FIG. 6). This is because the particles of Comparative Production Example 1 were detached from hydroxyapatite due to physical impact.
[粒子の多孔性確認試験]
製造例1で得た粒子10gを10N塩酸で3回洗浄処理し、結合しているハイドロキシアパタイトを除去した粒子を得た。得られた粒子を電子顕微鏡で観察し、図 7の像を得た。樹脂粒子は、ハイドロキシアパタイトを被覆しない場合に比べて表面の凹凸がやや粗く、多孔性粒子を形成していることが確認できた。
[Particle porosity confirmation test]
10 g of the particles obtained in Production Example 1 were washed with 10N hydrochloric acid three times to obtain particles from which the bonded hydroxyapatite was removed. The obtained particles were observed with an electron microscope to obtain the image of FIG. It was confirmed that the resin particles had slightly rough surface as compared with the case where the hydroxyapatite was not coated, and formed porous particles.
[吸油量測定]
製造例1、比較製造例1、比較製造例2で得られた粒子のスクワラン、及びオレイン酸の吸油量を測定した。皮脂に含まれる飽和脂肪酸にはスクワランが知られ、皮脂に含まれる不飽和脂肪酸にはオレイン酸が知られており、この2つの油剤に対する吸油量、湿潤点を測定することで皮脂の不飽和脂肪酸の選択的吸着性について知ることができる。
吸油量の測定は各試料5gをビーカーに精秤し、スクワラン又はオレイン酸を徐々に滴下しながら、その都度ヘラで十分に練りあわせて全体がパテ状のかたまりになったときの量を湿潤点とし、その後流動性が出るまでに必要な油の量を流動点として吸油量=流動点−湿潤点(ml/100g)とした。湿潤点が低いほど油になじみやすく、吸油量が多いほど油を多く保持できる。測定結果を下記表2に示す。
[Oil absorption measurement]
The oil absorption of squalane and oleic acid of the particles obtained in Production Example 1, Comparative Production Example 1 and Comparative Production Example 2 was measured. Squalane is known as the saturated fatty acid contained in sebum, and oleic acid is known as the unsaturated fatty acid contained in sebum. By measuring the oil absorption and wet point for these two oils, the unsaturated fatty acid in sebum It is possible to know about the selective adsorptivity of.
The amount of oil absorption is precisely weighed in a beaker with 5 g of each sample. Squalane or oleic acid is gradually added dropwise, and kneaded thoroughly with a spatula each time, and the amount when the whole becomes a putty-like mass is measured as the wet point. Then, the amount of oil required until fluidity was obtained was defined as oil absorption = pour point−wet point (ml / 100 g). The lower the wet point, the easier it is to adjust to the oil, and the higher the oil absorption, the more oil can be retained. The measurement results are shown in Table 2 below.
表2に示すように本発明の粒子はスクワランの吸油量が125.3、オレイン酸の吸油量が220.5と高く、特にオレイン酸の吸油量が高いことがわかった。またオレイン酸の湿潤点が23.2と低く、オレイン酸とはなじみやすいことが確認された。本発明の粒子は、従来の粒子と比較して選択的に不飽和脂肪酸特にオレイン酸を吸着することができる粒子であることが確認できた。 As shown in Table 2, it was found that the particles of the present invention had an oil absorption of squalane of 125.3 and an oil absorption of oleic acid as high as 220.5, and in particular, an oil absorption of oleic acid was high. Moreover, the wet point of oleic acid was as low as 23.2, and it was confirmed that it was easy to be familiar with oleic acid. The particles of the present invention were confirmed to be particles that can selectively adsorb unsaturated fatty acids, particularly oleic acid, as compared with conventional particles.
[実使用試験]
本発明の製造例1の粒子、比較製造例1,2の粒子を配合したパウダーファンデーション、クリームファンデーション、アイシャドウを調製し、実使用試験を行った。
[Real use test]
A powder foundation, a cream foundation, and an eye shadow containing the particles of Production Example 1 of the present invention and the particles of Comparative Production Examples 1 and 2 were prepared, and an actual use test was performed.
実施例1、比較例1、2の粒子を配合したパウダーファンデーションの組成
実施例1、比較例1、2の粒子を配合したアイシャドウの組成
実施例1、比較例1、2の粒子を配合したクリームファンデーション組成
本発明粒子を用いた配合例1〜3及び比較例1〜6実使用試験の評価結果を表6に示す。試験方法は女性20名に配合例1〜3及び比較例1〜6のサンプルを1週間使用させ、のび、ざらつき、べたつき、化粧もち及び密着性について評価した。尚、評価点は5点満点とし、1点を悪い〜5点を良いとして評価し、平均点を算出した。皮膚刺激性については、自己申告にて1名以上刺激が感じられた場合を×、感じられない、あるいは炎症の改善やニキビの改善などの改善効果が認められた場合を○として評価した。 Table 6 shows the evaluation results of Formulation Examples 1 to 3 and Comparative Examples 1 to 6 using the present particles. The test method was that 20 women were allowed to use the samples of Formulation Examples 1 to 3 and Comparative Examples 1 to 6 for 1 week, and evaluated for spread, roughness, stickiness, makeup, and adhesion. The evaluation score was a maximum of 5 points, 1 point was evaluated as bad to 5 points, and an average score was calculated. Regarding skin irritation, the case where irritation was felt by one or more persons by self-report was evaluated as x, and the case where no irritation was felt or improvement effects such as improvement of inflammation and acne were observed was evaluated as ◯.
本発明粒子を用いた配合例1〜3及び比較例1〜6実使用試験の評価結果
表6に示した結果のように本発明の粒子を配合した化粧料は、のびが良く、べたつきやざらつきもなく密着性と化粧もちに優れていることが確認された。さらに、皮膚刺激を訴えた人は一人もいなかった。また炎症状態の改善効果を有することが確認できた。 As shown in the results shown in Table 6, it was confirmed that the cosmetic containing the particles of the present invention had good spread and was excellent in adhesion and makeup without stickiness or roughness. In addition, no one complained of skin irritation. Moreover, it has confirmed that it had the improvement effect of an inflammatory state.
Claims (9)
A lipid component carrier containing the porous particles according to any one of claims 1 to 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004216076A JP4473667B2 (en) | 2003-07-24 | 2004-07-23 | Hydroxyapatite particle-bonded synthetic resin porous particles, external preparations, cosmetics |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003278688A JP2005041827A (en) | 2003-07-24 | 2003-07-24 | Porous particle of synthetic resin bonded with hydroxy apatite particle, external preparation and cosmetic |
JP2004216076A JP4473667B2 (en) | 2003-07-24 | 2004-07-23 | Hydroxyapatite particle-bonded synthetic resin porous particles, external preparations, cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005112847A true JP2005112847A (en) | 2005-04-28 |
JP4473667B2 JP4473667B2 (en) | 2010-06-02 |
Family
ID=34554136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004216076A Expired - Lifetime JP4473667B2 (en) | 2003-07-24 | 2004-07-23 | Hydroxyapatite particle-bonded synthetic resin porous particles, external preparations, cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4473667B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009280753A (en) * | 2008-05-26 | 2009-12-03 | Nitto Denko Corp | Method for producing dry powder of porous polymer particle |
WO2017026424A1 (en) * | 2015-08-10 | 2017-02-16 | 国立大学法人京都大学 | Porous particle, method for producing porous particle, and block copolymer |
WO2017026426A1 (en) * | 2015-08-10 | 2017-02-16 | 国立大学法人京都大学 | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer |
JP2021107366A (en) * | 2019-12-27 | 2021-07-29 | 花王株式会社 | Cosmetics |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03101608A (en) * | 1989-09-14 | 1991-04-26 | Hitachi Chem Co Ltd | Cosmetic ingredient |
JPH0532524A (en) * | 1991-07-31 | 1993-02-09 | Sekisui Plastics Co Ltd | Production of porous spherical apatite particle |
JPH06107709A (en) * | 1992-09-25 | 1994-04-19 | Tosoh Corp | Production of porous polymer particle |
JP2002265529A (en) * | 2001-03-14 | 2002-09-18 | Sekisui Plastics Co Ltd | Porous resin particle and external preparation prepared by compounding the same |
-
2004
- 2004-07-23 JP JP2004216076A patent/JP4473667B2/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03101608A (en) * | 1989-09-14 | 1991-04-26 | Hitachi Chem Co Ltd | Cosmetic ingredient |
JPH0532524A (en) * | 1991-07-31 | 1993-02-09 | Sekisui Plastics Co Ltd | Production of porous spherical apatite particle |
JPH06107709A (en) * | 1992-09-25 | 1994-04-19 | Tosoh Corp | Production of porous polymer particle |
JP2002265529A (en) * | 2001-03-14 | 2002-09-18 | Sekisui Plastics Co Ltd | Porous resin particle and external preparation prepared by compounding the same |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009280753A (en) * | 2008-05-26 | 2009-12-03 | Nitto Denko Corp | Method for producing dry powder of porous polymer particle |
WO2017026424A1 (en) * | 2015-08-10 | 2017-02-16 | 国立大学法人京都大学 | Porous particle, method for producing porous particle, and block copolymer |
WO2017026426A1 (en) * | 2015-08-10 | 2017-02-16 | 国立大学法人京都大学 | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer |
JPWO2017026424A1 (en) * | 2015-08-10 | 2018-06-14 | 国立大学法人京都大学 | Porous particles, method for producing porous particles, and block copolymer |
JPWO2017026426A1 (en) * | 2015-08-10 | 2018-06-14 | 国立大学法人京都大学 | Organic polymer porous particles, method for producing organic polymer porous particles, and block copolymer |
US10858491B2 (en) | 2015-08-10 | 2020-12-08 | Kyoto University | Porous particle made of organic polymer, method for producing porous particle made of organic polymer, and block copolymer |
JP2021107366A (en) * | 2019-12-27 | 2021-07-29 | 花王株式会社 | Cosmetics |
JP7385470B2 (en) | 2019-12-27 | 2023-11-22 | 花王株式会社 | cosmetics |
Also Published As
Publication number | Publication date |
---|---|
JP4473667B2 (en) | 2010-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5642384B2 (en) | Granulated silica particles, composite powder, production method thereof, and cosmetics containing them | |
RU2529796C2 (en) | Cosmetic preparation in form of powder and method of obtaining thereof | |
EP2415457A1 (en) | Solid powder cosmetic and method for producing the same | |
JP3888856B2 (en) | Porous resin fine particles and external preparation containing the same | |
WO2019151486A1 (en) | Functional polysaccharide particle | |
JP5433128B2 (en) | Topical skin preparation | |
KR101747661B1 (en) | Porous resin particles, method of manufacturing porous resin particles, dispersion liquid, and use of porus resin particles | |
WO2006103879A1 (en) | Hydrous powdery cosmetic preparation | |
JP2016104869A (en) | Porous resin particle and application thereof | |
JP7189202B2 (en) | Phosphorylcholine group- and silicone group-containing copolymer, powder coated with the copolymer, production method thereof, and use of the copolymer and powder in cosmetics | |
WO2014163310A1 (en) | Method for preparing macroporous polymethyl methacrylate | |
JP2003301019A (en) | Water absorptive polymer particle with hydrophobic surface | |
Tiwari et al. | Microsponge: An augmented drug delivery system | |
JP4473667B2 (en) | Hydroxyapatite particle-bonded synthetic resin porous particles, external preparations, cosmetics | |
JP2005041827A (en) | Porous particle of synthetic resin bonded with hydroxy apatite particle, external preparation and cosmetic | |
JP5156182B2 (en) | Cosmetic composition | |
JP2002265620A (en) | Wet material of (meth)acrylic acid ester-based resin particle, method for producing the same and external preparation | |
EP1402875A1 (en) | Powdery composition | |
JP2014237628A (en) | Cosmetic | |
JP2891262B2 (en) | Cosmetics | |
JP6170312B2 (en) | Water-containing powder cosmetic | |
JP6034618B2 (en) | Cosmetics | |
JP2004315425A (en) | Cosmetic composition | |
JP2008120715A (en) | Cosmetic composition | |
JP2000302624A (en) | Acrylic acid ester-based resin particle and external preparation containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20040817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040819 Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040819 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070507 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090515 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090519 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20090717 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090717 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100208 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100302 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100305 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130312 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4473667 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130312 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130312 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140312 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |